Disclosed are diagnostic methods that permit a reduction of risk of mortalityin infantswho are candidates for treatment with inhaled nitric oxide, by identifying asubset of suchinfants who are at an increased risk of mortality upon treatment with inhalednitric oxide;also disclosed are related uses and systems for use in administering inhalednitric oxideand methods of distributing a pharmaceutical product.